This systematic review and meta-analysis examined randomized controlled trials investigating nicotinamide mononucleotide (NMN) supplementation and its effects on blood pressure outcomes. The analysis synthesized data from human clinical trials to evaluate whether NMN supplementation produces measurable changes in systolic and diastolic blood pressure readings. This evidence represents a human clinical level of evidence derived from aggregated randomized controlled trial data.